Select your language close

Christine Dahl 医生

Consultant Oncologist


Dr Christine Dahl joined GOSH in June 2018 and she is leading the multidisciplinary Neuro-Oncology aftercare clinic at GOSH. She trained in Denmark as well as in Canada (SickKids Toronto).

Dr Dahl's special interest is in neuro-oncology and long-term side effects in children surviving brain tumours.


  • English, Danish, French, Swedish


  • Paediatric brain tumours and long term side effects

  • Germ Cell Tumours / Extracranial Teratomas

  • Pancreatic neuroendocrine tumours (PNETs) 

  • Paediatric brain tumours and long term side effects

  • Germ Cell Tumours / Extracranial Teratomas

  • Pancreatic neuroendocrine tumours (PNETs) 

  • MD 1997
  • PhD 1998-2002
  • Internship 2003-2004
  • Training in paediatrics 2004-2010
  • Haematology/Oncology 2010-2012, Denmark
  • Paediatric neonatology/Intensive Care 2012-2015, Denmark
  • Paediatric Haematology/Oncology 2015-2016, Denmark
  • Chief fellow Neuro-Oncology 2016-2017, SickKids, Toronto
  • Paediatric Haematology/Oncology 2017-2018, Denmark
  • Paediatric Oncology, 2018-now, GOSH, London


  • Member of Children's Cancer and Leukaemia Group (CCLG) and Nordic Society for Paediatric Haematology and Oncology (NOPHO)
  • Member of PanCare

Long term side effects after treatment for brain tumours in children and adolescents


Moxon-Emre I,  Dahl C, Ramaswamy V, Bartels U, Tabori U, Huang A, Cushing SL, Papaioannou V, Laperriere N, Bouffet E, Mabbott DJ.

          Hearing loss and intellectual outcome in children treated for malignant brain tumors: implications for young children treated with radiation sparing approaches

          Paper submitted to J Neuro Oncology 2020

Dahl C, Von Ottingen G, Elmedahl B, Lassen Y. Dramatic response in a child treated for glioblastoma with immune check point inhibitor. ISPNO 2018

Dahl C., Saito H., Nielsen H. V. and Schiotz P. O., The establishment of a combined serum free and serum supplemented culture method of obtaining functional human cord blood derived mast cells. J. Immunol Methods 2002; 262 (1-2):137-43

Hoffmann HJ, Dahl C, Schiotz PO, Berglund L, Dahl R. Lectins interact differentially with purified human eosinophils, cultured cord blood-derived mast cells and the myeloid leukaemic cell line AML14.3D10: induction of interleukin-4 secretion is conserved among granulocytes, but is not proportional to agglutination or lectin-glycoprotein interaction. Clin Exp Allergy. 2003;33(7):930-5.

Dahl C., Hoffmann H.J., Saito H., Schiotz P.O., Human mast cells express receptors for IL-3, IL-5 and GM-CSF; a partial map of receptors on human mast cells cultured in vitro. Allergy. 2004; 59(10):1087-1096

Dahl C, Saito H, Kruhøffer M and Schiotz PO Identification of tryptase- and chymase-related gene clusters in human mast cells using microarrays Allergy 2006; 61(3):276-807.

Holm M, Kvistgaard H, Dahl C, Andersen HB, Hansen TK, Schiøtz PO, Junker S. Modulation of chemokine gene expression in CD133+ cord blood derived human mast cells by cyclosporine A and dexamethasone. Scand J Immunol 2006; 64(5):571-9

Dahl C, Fursted K, Schrøser H. A paediatric case of Candida pericarditis and eosophagus stricture during treatment for acute lymphatic leukaemia. Acta Oncol 2007; 46(6):859-61

Holm M, Andersen HB, Hetland TE, Dahl C, Hoffmann HJ, Junker S, Schiotz PO, Seven Week Culture of Functional Human Mast Cells from Buffy Coat Preparations. J Immunol Methods 2008; 336(2):213-21

Andersen HB, Holm M, Hetland TE, Dahl C, Hoffmann HJ, Junker S, Schiotz PO Comparison of short term in vitro cultured human mast cells from different progenitors - peripheral blood-derived progenitors generate highly mature and functional mast cells. J Immunol Methods 2008; 336(2):166-74

转诊您的孩子至Christine Dahl 医生


下一步: 患者资料


Christine Dahl 医生详情

您可以通过大奥蒙德街儿童医院的以下联系方式与Christine Dahl 医生取得联系

与他人分享Christine Dahl 医生的履历